For more than two decades, Professor Edwin Chan Ho-yin has pursued one of medicine’s toughest challenges by developing treatments for rare neurodegenerative diseases.
His pioneering work, now channelled through his biotech start-up Rare Power, bridges academic discovery with real-world application, earning him a place as a finalist in this year’s Spirit of Hong Kong Awards in the Innovation category.
The Spirit of Hong Kong Awards, co-organised by the South China Morning Post and Sino Group,…